Navidea Biopharmaceuticals (NAVB) Stock Chart & Stock Price History $0.0001 0.00 (-50.00%) As of 03/17/2025 09:53 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrends Navidea Biopharmaceuticals Stock Price Performance 5 Day Performance0.00%1 Month Performance-87.50%3 Month Performance0.00%6 Month Performance-90.00%Year-To-Date Performance0.00%1 Year Performance-99.73% Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address NAVB Stock Chart for Wednesday, March, 19, 2025 NAVB Chart by TradingViewRemove Ads Navidea Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/18/2025$0.00$0.00$0.00$0.0011,000 shs$10,000.0003/17/2025$0.00$0.00$0.00$0.0011,000 shs$10,000.0003/14/2025$0.00$0.00$0.00$0.001,005 shs$10,000.0003/13/2025$0.00$0.00$0.00$0.00321 shs$10,000.0003/12/2025$0.00$0.00$0.00$0.004,000 shs$10,000.0003/11/2025$0.00$0.00-50.00%$0.00$0.00225 shs$10,000.0003/10/2025$0.00$0.00$0.00$0.00184 shs$20,000.0003/07/2025$0.00$0.00+100.00%$0.00$0.00184 shs$20,000.0003/06/2025$0.00$0.00$0.00$0.002,555 shs$10,000.0003/05/2025$0.00$0.00-50.00%$0.00$0.002,555 shs$10,000.00 Get the Latest News and Ratings for NAVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/04/2025$0.00$0.00+100.00%$0.00$0.00100 shs$20,000.0003/03/2025$0.00$0.00-88.89%$0.00$0.00741 shs$10,000.0002/27/2025$0.00$0.00$0.00$0.003,220 shs$90,000.0002/26/2025$0.00$0.00$0.00$0.003,220 shs$90,000.0002/25/2025$0.00$0.00+12.50%$0.01$0.0041,598 shs$90,000.0002/24/2025$0.00$0.00$0.00$0.00347 shs$80,000.0002/21/2025$0.00$0.00$0.00$0.00190 shs$80,000.0002/20/2025$0.00$0.00$0.00$0.00190 shs$80,000.0002/19/2025$0.00$0.00+14.29%$0.00$0.001,252 shs$80,000.0002/18/2025$0.00$0.00$0.00$0.00514 shs$70,000.00 Related Companies Smart for Life Stock Chart Scopus BioPharma Stock Chart Evelo Biosciences Stock Chart Comera Life Sciences Stock Chart Genocea Biosciences Stock Chart Genocea Biosciences Stock Chart Aridis Pharmaceuticals Stock Chart Statera Biopharma Stock Chart Calithera Biosciences Stock Chart eFFECTOR Therapeutics Stock Chart Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NAVB) was last updated on 3/19/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
